Detailed price information for Sonnet Biotherapeutics Holdings Inc (SONN-Q) from The Globe and Mail including charting and trades.

Combined company expected to become largest U.S.-based publicly listed company to hold HYPE in its treasuryPRINCETON, N.J., July 14, 2025 ( ...

Agreement with global pharmaceutical solutions provider enhances commercial infrastructure and reinforces launch readiness ...

Investing.com -- Citius Oncology, Inc. (NASDAQ: CTOR) stock rose 4.1% after announcing a distribution services agreement with Cencora for its FDA-approved immunotherapy LYMPHIR.

Citius Oncology, Inc. (NASDAQ:CTOR) saw its stock rise 4.1% after announcing a new distribution services agreement with Cencora to broaden the reach of its FDA-approved immunotherapy, LYMPHIR. The ...

Peptides have emerged as a fascinating area of scientific inquiry due to their potential to modulate various physiological ...

Interest grows in plasma proteins for sports supplements and medical foods, driven by their amino acid profilesDublin, July 15, 2025 (GLOBE NEWSWIRE) -- The "Plasma Protein Powder Market Size, Share, ...

Discover what glycan analysis can reveal about protein behavior and how it can be used to boost biologic performance and ...

Lotte Bjerre Knudsen, Chief Scientific Adviser for Research at Danish pharma giant Novo Nordisk, speaks about GLP-1-based ...

Why Supreme Court of India’s observation on social media is relevant to the UPSC exam? What is the significance of topics ...